Podocyte injury damages other podocytes

Journal of the American Society of Nephrology

Volumn 22, Issue 7, 2011, Pages 1275-1285

  Matsusaka, Taiji ^a   Sandgren, Eric ^b   Shintani, Ayumi ^c   Kon, Valentina ^c   Pastan, Ira ^d   Fogo, Agnes B ^c   Ichikawa, Iekuni ^a,c  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; DESMIN; IMMUNOTOXIN LMB2; INTERLEUKIN 2 RECEPTOR ALPHA; NEPHRIN; PODOCALYXIN; PODOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; MALE; MICROVILLUS; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; SCLEROSIS; UPREGULATION;

EID: 79960113480     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010090963     Document Type: Article

References (47)

1. LeHir M, Kriz W: New insights into structural patterns encountered in glomerulosclerosis. Curr Opin Nephrol Hypertens 16: 184-191, 2007
2. D'Agati VD: Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts). Kidney Int 73: 399-406, 2008
3. Wiggins RC: The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int 71: 1205-1214, 2007
4. Barisoni L, Schnaper HW, Kopp JB: A proposed taxonomy for the podocytopathies: A reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2: 529-542, 2007
5. Mundel P, Shankland SJ: Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005-3015, 2002 (Pubitemid 35386921)
6. Tryggvason K, Patrakka J, Wartiovaara J: Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354: 1387-1401, 2006
7. Zenker M, Machuca E, Antignac C: Genetics of nephrotic syndrome: New insights into molecules acting at the glomerular filtration barrier. J Mol Med 87: 849-857, 2009
8. Shah SN, He CJ, Klotman P: Update on HIV-associated nephropathy. Curr Opin Nephrol Hypertens 15: 450-455, 2006 (Pubitemid 44297989)
9. Stitt-Cavanagh E, MacLeod L, Kennedy C: The podocyte in diabetic kidney disease. ScientificWorldJournal 9: 1127-1139, 2009
10. Matsusaka T, Xin J, Niwa S, Kobayashi K, Akatsuka A, Hashizume H, Wang QC, Pastan I, Fogo AB, Ichikawa I: Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol 16: 1013-1023, 2005 (Pubitemid 41710312)
11. Kreitman RJ, Pastan I: Accumulation of a recombinant immunotoxin in a tumor in vivo: Fewer than 1000 molecules per cell are sufficient for complete responses. Cancer Res 58: 968-975, 1998 (Pubitemid 28182466)
12. Ichikawa I, Ma J, Motojima M, Matsusaka T: Podocyte damage damages podocytes: Autonomous vicious cycle that drives local spread of glomerular sclerosis. Curr Opin Nephrol Hypertens 14: 205-210, 2005 (Pubitemid 40685630)
13. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307: 652-659, 1982 (Pubitemid 12049914)
14. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241: F85-F93, 1981 (Pubitemid 11033923)
15. Miller PL, Scholey JW, Rennke HG, Meyer TW: Glomerular hypertrophy aggravates epithelial cell injury in nephrotic rats. J Clin Invest 85: 1119-1126, 1990 (Pubitemid 20123753)
16. Fogo A, Ichikawa I: Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis. Am J Kidney Dis 17: 666-669, 1991
17. Nagata M, Kriz W: Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 42: 148-160, 1992
18. Wiggins JE, Goyal M, Sanden SK, Wharram BL, Shedden KA, Misek DE, Kuick RD, Wiggins RC: Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: Prevention by calorie restriction. J Am Soc Nephrol 16: 2953-2966, 2005 (Pubitemid 44743493)
19. Kisseberth WC, Brettingen NT, Lohse JK, Sandgren EP: Ubiquitous expression of marker transgenes in mice and rats. Dev Biol 214: 128-138, 1999 (Pubitemid 29463361)
20. Hostetter TH: Hyperfiltration and glomerulosclerosis. Semin Nephrol 23: 194-199, 2003
21. Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M, Chang JW, Wiggins JE, Lienczewski C, Kretzler M, Wiggins RC: Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol 20: 1041-1052, 2009
22. Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L, Kershaw D, Wiggins R: Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 60: 957-968, 2001 (Pubitemid 34205795)
23. Shirato I, Hosser H, Kimura K, Sakai T, Tomino Y, Kriz W: The development of focal segmental glomerulosclerosis in Masugi nephritis is based on progressive podocyte damage. Virchows Arch 429: 255-273, 1996 (Pubitemid 26402669)
24. Shankland SJ: The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006
25. Schwartz MM, Bidani AK, Lewis EJ: Glomerular epithelial cell function and pathology following extreme ablation of renal mass. Am J Pathol 126: 315-324, 1987 (Pubitemid 17033856)
26. Olson JL, Hostetter TH, Rennke HG, Brenner BM, Venkatachalam MA: Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 22: 112-126, 1982 (Pubitemid 12061645)
27. Mollet G, Ratelade J, Boyer O, Muda AO, Morisset L, Lavin TA, Kitzis D, Dallman MJ, Bugeon L, Hubner N, Gubler MC, Antignac C, Esquivel EL: Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome. J Am Soc Nephrol 20: 2181-2189, 2009
28. Pollak MR: Surprising results following conditional podocyte inactivation. J Am Soc Nephrol 20: 2086-2088, 2009
29. Kriz W: The pathogenesis of "classic" focal segmental glomerulosclerosis - Lessons from rat models. Nephrol Dial Transplant 18[Suppl 6]: vi39-vi44, 2003
30. Asano T, Niimura F, Pastan I, Fogo AB, Ichikawa I, Matsusaka T: Permanent genetic tagging of podocytes: Fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol 16: 2257-2262, 2005 (Pubitemid 41725042)
31. Abbate M, Zoja C, Morigi M, Rottoli D, Angioletti S, Tomasoni S, Zanchi C, Longaretti L, Donadelli R, Remuzzi G: Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: A central pathway in progressive glomerulosclerosis. Am J Pathol 161: 2179-2193, 2002 (Pubitemid 35434863)
32. Wu DT, Bitzer M, Ju W, Mundel P, Bottinger EP: TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol 16: 3211-3221, 2005 (Pubitemid 46179327)
33. Morigi M, Buelli S, Angioletti S, Zanchi C, Longaretti L, Zoja C, Galbusera M, Gastoldi S, Mundel P, Remuzzi G, Benigni A: In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: Implication for permselective dysfunction of chronic nephropathies. Am J Pathol 166: 1309-1320, 2005
34. Collino F, Bussolati B, Gerbaudo E, Marozio L, Pelissetto S, Benedetto C, Camussi G: Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 294: F1185-F1194, 2008
35. Sayyed SG, Hagele H, Kulkarni OP, Endlich K, Segerer S, Eulberg D, Klussmann S, Anders HJ: Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia 52: 2445-2454, 2009
36. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, Liu Y: Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20: 1997-2008, 2009
37. Onda M, Vincent JJ, Lee B, Pastan I: Mutants of immunotoxin anti-Tac(dsFv)-PE38 with variable number of lysine residues as candidates for site-specific chemical modification. 1. Properties of mutant molecules. Bioconjug Chem 14: 480-487, 2003
38. Yaoita E, Yao J, Yoshida Y, Morioka T, Nameta M, Takata T, Kamiie J, Fujinaka H, Oite T, Yamamoto T: Up-regulation of connexin43 in glomerular podocytes in response to injury. Am J Pathol 161: 1597-1606, 2002 (Pubitemid 35265520)
39. Matsusaka T, Kobayashi K, Kon V, Pastan I, Fogo AB, Ichikawa I: Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protection. Am J Physiol Renal Physiol 300: F792-F800, 2011
40. Remuzzi G: Nephropathic nature of proteinuria. Curr Opin Nephrol Hypertens 8: 655-663, 1999
41. Bazzi C, Petrini C, Rizza V, Arrigo G, D'Amico G: A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Kidney Int 58: 1732-1741, 2000
42. Bakoush O, Grubb A, Rippe B, Tencer J: Urine excretion of protein HC in proteinuric glomerular diseases correlates to urine IgG but not to albuminuria. Kidney Int 60: 1904-1909, 2001
43. Remuzzi G, Ruggenenti P, Perico N: Chronic renal diseases: Renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 136: 604-615, 2002 (Pubitemid 34407045)
44. Keane WF, Brenner BM, de Zeeuw D, Grunfeld JP, McGill J, Mitch WE, Ribeiro AB, Shahinfar S, Simpson RL, Snapinn SM, Toto R: The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL study. Kidney Int 63: 1499-1507, 2003 (Pubitemid 36350016)
45. Farquhar MG, Palade GE: Glomerular permeability. II. Ferritin transfer across the glomerular capillary wall in nephrotic rats. J Exp Med 114: 699-716, 1961
46. Kriz W: Progression of chronic renal failure in focal segmental glomerulosclerosis: Consequence of podocyte damage or of tubulointerstitial fibrosis? Pediatr Nephrol 18: 617-622, 2003
47. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC: Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952, 2005 (Pubitemid 44743492)